Taro Pharmaceutical Industries Ltd. Announces Preliminary Results Of Its Self-Tender Offer

Published: Dec 27, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today announced the preliminary results of its modified “Dutch auction” tender offer to repurchase up to $200 million in value of its ordinary shares, which expired at 12:00 midnight, New York City time, on Monday, December 23, 2013. Based on the preliminary count by American Stock Transfer & Trust Company, LLC (“AST”), the Depositary for the tender offer, approximately 1.96 million ordinary shares were properly tendered and not properly withdrawn at or below the expected final purchase price of $97.50 per share, including shares that were tendered through notices of guaranteed delivery.

Help employers find you! Check out all the jobs and post your resume.

Back to news